GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Enterprise Value

Allurion Technologies (Allurion Technologies) Enterprise Value : $90.26 Mil (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Allurion Technologies's Enterprise Value is $90.26 Mil. Allurion Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-46.65 Mil. Therefore, Allurion Technologies's EV-to-EBIT ratio for today is -1.93.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Allurion Technologies's Enterprise Value is $90.26 Mil. Allurion Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-45.79 Mil. Therefore, Allurion Technologies's EV-to-EBITDA ratio for today is -1.97.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Allurion Technologies's Enterprise Value is $90.26 Mil. Allurion Technologies's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $48.78 Mil. Therefore, Allurion Technologies's EV-to-Revenue ratio for today is 1.85.


Allurion Technologies Enterprise Value Historical Data

The historical data trend for Allurion Technologies's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Enterprise Value Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23
Enterprise Value
- - 182.17

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 185.28 182.17 95.92

Competitive Comparison of Allurion Technologies's Enterprise Value

For the Medical Devices subindustry, Allurion Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's Enterprise Value falls into.



Allurion Technologies Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Allurion Technologies's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Allurion Technologies's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allurion Technologies  (NYSE:ALUR) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Allurion Technologies's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=90.255/-46.654
=-1.93

Allurion Technologies's current Enterprise Value is $90.26 Mil.
Allurion Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.65 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Allurion Technologies's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=90.255/-45.786
=-1.97

Allurion Technologies's current Enterprise Value is $90.26 Mil.
Allurion Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-45.79 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Allurion Technologies's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=90.255/48.781
=1.85

Allurion Technologies's current Enterprise Value is $90.26 Mil.
Allurion Technologies's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $48.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allurion Technologies Enterprise Value Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Allurion Technologies (Allurion Technologies) Business Description

Traded in Other Exchanges
N/A
Address
11 Huron Drive, Natick, MA, USA, 01760
Website
Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Executives
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta director, 10 percent owner 307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth officer: Chief Financial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin director C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson director 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon officer: Chief Commercial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur director, officer: Chief Executive Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani officer: Chief Medical Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760